Toshi Tanuiguchi, M.D., Ph.D., Elizabeth M. Swisher, M.D.

Defining Genomic Scarring and Functional DNA Variants that Predict Response to PARP Inhibitors in a Clinical Trial for Recurrent Ovarian Cancer